MT Group is a leading biospecimen CRO with over 20 years of experience in the field. We specialize in providing biospecimen products and services to pharmaceutical, biotechnology, and diagnostic companies. Our mission is to support researchers in their quest for disease insights and future therapies by providing them with the right biospecimens collected in the right way.

We have worked hard to establish robust biospecimen collection, storage, and transport systems, earning the trust of our customers along the way. Our track record speaks for itself, as we have supported numerous medical advancements, from standard therapy to targeted therapy to immuno-oncology checkpoint inhibitors, and even COVID-19 vaccines and treatments. What sets us apart is our commitment to comprehensive clinical annotation, ensuring that our biospecimens are contextualized for translational research.

We value partnerships over transactions and take the time to understand our customers' study goals. With our optimized quality system, we guarantee the delivery of specimens that meet your standards. Join us in driving diagnostic and therapeutic options for patient care.

Contact us to get started